wow., time to buyโฆ ๐๐โฌ๏ธ๐๐๐
$Summit Therapeutics (SMMT.US)$ ย $5 billion exclusive license deal with Nasdaq-listed Summit Therapeutics to develop and commercialize ivonescimab in the US, Canada, Europe and Japan
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
